FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

25254000: Procainamide hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
42334019 Procainamide hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
42335018 Procaine amide hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
755550017 Procainamide hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
835671000172111 chlorhydrate de procaïnamide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Procainamide hydrochloride Is a Product containing procainamide (medicinal product) false Inferred relationship Some
Procainamide hydrochloride Is a Procainamide (substance) false Inferred relationship Some
Procainamide hydrochloride Is a Drug allergen by structure false Inferred relationship Some
Procainamide hydrochloride Is a Class Ia antiarrhythmic agent (substance) true Inferred relationship Some
Procainamide hydrochloride Is a Benzamide (substance) false Inferred relationship Some
Procainamide hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Procainamide (substance) true Inferred relationship Some
Procainamide hydrochloride Is a Substance with benzamide structure true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
chlorhydrate de procaïnamide 100 mg/mL, ampoule de 10 mL de solution pour injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some
Procainamide hydrochloride 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some
Procainamide hydrochloride 375 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some
Procainamide hydrochloride 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some
Product containing precisely procainamide hydrochloride 500 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some
Procainamide hydrochloride 250 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some
Procainamide hydrochloride 1000mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some
Procainamide hydrochloride 500mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some
Procainamide hydrochloride 250mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some
Procainamide hydrochloride 750mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some
Procainamide hydrochloride 500mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some
Procainamide hydrochloride 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some 1
Procainamide hydrochloride 250 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Procainamide hydrochloride Inferred relationship Some 1
Procainamide hydrochloride 375 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some 1
Procainamide hydrochloride 375 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Procainamide hydrochloride Inferred relationship Some 1
Procainamide hydrochloride 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some 1
Procainamide hydrochloride 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Procainamide hydrochloride Inferred relationship Some 1
Product containing precisely procainamide hydrochloride 500 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some 1
Product containing precisely procainamide hydrochloride 500 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Procainamide hydrochloride Inferred relationship Some 1
Procainamide hydrochloride 250 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some 1
Procainamide hydrochloride 250 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Procainamide hydrochloride Inferred relationship Some 1
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some 1
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Procainamide hydrochloride Inferred relationship Some 1
Procainamide hydrochloride 750mg prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some
Procainamide hydrochloride 250mg prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Procainamide hydrochloride Inferred relationship Some
Procainamide hydrochloride 500 mg prolonged-release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Procainamide hydrochloride Inferred relationship Some 1
Procainamide hydrochloride 500 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Procainamide hydrochloride Inferred relationship Some 1
Product containing precisely procainamide hydrochloride 1 gram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Procainamide hydrochloride Inferred relationship Some 1
Product containing precisely procainamide hydrochloride 1 gram/1 each prolonged-release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Procainamide hydrochloride Inferred relationship Some 1
Procainamide hydrochloride 250 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Procainamide hydrochloride Inferred relationship Some 1
Procainamide hydrochloride 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Procainamide hydrochloride Inferred relationship Some 1
Product containing precisely procainamide hydrochloride 500 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Procainamide hydrochloride Inferred relationship Some 1
Procainamide hydrochloride 250 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Procainamide hydrochloride Inferred relationship Some 1
Product containing precisely procainamide hydrochloride 375 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Procainamide hydrochloride Inferred relationship Some 1
Procainamide hydrochloride 375 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Procainamide hydrochloride Inferred relationship Some 1

This concept is not in any reference sets

Back to Start